1145A Phase 2, Open-Label, Multi-Center, Randomized Trial To Demonstrate The Pharmacokinetics Of LCP-Tacro Tablets Once Daily and Prograf Capsules Twice Daily In Adult De Novo Kidney Transplant Patients.

Trial Profile

1145A Phase 2, Open-Label, Multi-Center, Randomized Trial To Demonstrate The Pharmacokinetics Of LCP-Tacro Tablets Once Daily and Prograf Capsules Twice Daily In Adult De Novo Kidney Transplant Patients.

Completed
Phase of Trial: Phase II

Latest Information Update: 22 May 2015

At a glance

  • Drugs Tacrolimus (Primary)
  • Indications Renal transplant rejection
  • Focus Pharmacokinetics
  • Most Recent Events

    • 03 Jul 2012 Actual end date (Feb 2010) added as reported by ClinicalTrials.gov.
    • 03 Jul 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 04 May 2011 Results presented at the American Transplant Congress -- 11th Joint Congress of the American Society of Transplant Surgeons and the American Society of Transplantation.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top